Driving the growth of many cancerous tumours is a protein known as SALL4, which has been classified as an "undruggable target".
But scientists from the National University of Singapore (NUS) and Harvard Medical School believe they have found a solution in a new drug.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
